Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.
Placing not ideal but moves us closer so did a few top ups at below 8.3p Noticed that it became NT to buy and could sell in volume so looks like MM are trying to shake out weak holders. Also quoted spread was very wide v actual was narrow to make buys look like sells
Raul Pal said as much a few days ago
https://twitter.com/sharetell/status/1358741142439944193
Great finish to the year in seeing ARB finally come good; it has required a lot of patience over the past few years especially in the lows of the summer. In my crypto investments, I have 90% of ARB and 10% in KR1. KR1 are a dark horse; they have been early into the crypto space and their large polkadot holding generates significant staking revenues and allows them to invest in other projects that leverage the polkadot infrastructure. This pooled approach could turn up a gem and add value to their polkadot holding. They also have additional investments in other crypto tokens so a good low risk way to invest in the wider crypto space. The outlook for BTC is looking brighter still and ARB is a good leverage play into this. Raoul Pal and Michael Saylor's advocacy for BTC is really compelling and despite my previous reluctance to invest directly in crypto I have now bought my first BTC a few months ago. I bought ARB a few years ago as a hedge against the rest of my stock portfolio. I was nervous about the constant money printing and low interest rates that made generating income for retirement difficult. Now it turns out ARB has now become a large percentage of my portfolio. I don't normally have time to post here but have enjoyed reading the quality contributions here during 2020. Happy Christmas all and looking forward to the bright future for ARB/ KR1in 2021
To be far to TB, it doesn't take a genius to see that RMS was vastly overvalued after going up over 10 times (sold out myself but not at the top unfortunately). Hence, it was in the best interest of BRH to sell out at these inflated prices; the directors of RMS selling out was another warning sign that things had got ahead of themselves. Awarding options so soon to today's good news was a bit on the naughty side so not sure how he got away with that. However, I can't complain with the returns from BRH so far and happy to stay invested.
I am assuming that on Spreadex you are being paid the dividend value per share to compensate for the fact that the shares will drop on the 10th (today the ex-dividend date) by 42.75p.
With the real shares, it is probably best to hold the shares until close of play Thursday to ensure being on the register for payment of dividend. With both shares and Spreadex, you could safely sell on the 11th and still get dividend.
You might even be able to sell on 10th (today) on Spreadex but not 100% sure on this.
Billfunk1 - KR1 are on the NEX exchange and when I tried a few months ago AJBell didn't allow dealing on this exchange. Hence, I had to open an account on Hargreaves and even then it required telephone dealing. As a result KR1 is very illiquid and the spread can be wide. However, I think it could be one to buy and tuck away as some of its big bets taken a few years are coming good. It is also generating significant staking revenues from its various investments.
PeterS23 not sure I would agree with your statement "more of the same’ to people who’ve been invested here for a while"
I was expecting more of the same but last night as I have seen Cathal present numerous times. However, last night he excelled himself and could not sit still he was so excited, so suspect despite the nuggets of news he dropped, there may be more he was holding back. The fact that Amazon and Apple are interested in our data and it could be worth more than the market cap is significant. It is company maker news by itself - but there is more. Secondly, we have the use of the Royal Free longer term for a nominal rent (double OO's capacity for Human Challenge Trials). Thirdly, OO are looking at other sites around the world to carry out Human Challenge Trials. This includes the USA where jobs are being advertised so this must be at an advanced stage. Cathal was coy when that was mentioned. Fourthly, vaccines are in focus and OO are looking to developed additional Challenge Models funded by the drug companies so as Cathal says the next 10 years will be all about vaccines. Lastly, the ambitions have changed, Cathal talked about growing it into a billion pound company. OO have no competition and a moat and are uniquely placed. I suggest you watch his presentation again https://www.youtube.com/watch?v=VGGRadLPLqs starting at 1:35:35
Only got just over a third of what I applied for and I am an existing shareholders.
I world be interested to know how the allocation works. Does it depend on how early you apply and how much impact does being an existing shareholders have?
Anyone know?
hard to sell at the moment at best - typical on a down day investors are spooked and sometimes rush for the door trying to lock in a profit before it disappears (some have probably double or trebled their money so I can understand the psychology) . However, if you have done your research this is the time to accumulate. Despite being overweight I have added but will probably trade these additional shares when OO inevitably goes back to the 30s. It might go lower but will be driven by the US market and sentiment rather than fundamentals. Also hoping Cathal is on form tomorrow night. In any case, keeping some powder dry for other bargains. Open Orphan is one of the safest shares in these choppy markets and has significant upside that is not solely dependent on COVID. On days like this, it is best to add more bargain shares (ones you have conviction in) and go for a long walk and stop watching the minute by minutes changes in the market. Long term it will be good for your wealth
Hvivo fixed costs are £10m so this is covered by one challenge study. The variable costs for each future challenge study are less than 25% of cost. Hence this is lucrative high margin business once the fixed cost are covered. It is 60% plus with turnover of £80m including fixed costs. This will be throwing off cash so making a regular dividend a strong possibility as Cathal will be keen to realise a return. This business has a moat and is in high demand and hence has pricing power as seen by the recent increase in cost of their human Challenge studies. In addition, they can licence their human Challenge models for more high margin returns. Once the market catches on that this is not a fly by night covid stock it could be many multiples of today's price. I am fully loaded here and am breaking my own allocation rule as OO is now around 23% of my portfolio. Otherwise I would add more. Add in the wildcards of Imutex sale and the potential of data sale to a wearables company, I will have to sit on my hands to stop myself buying more.
I also think that Peter Walls should create more publicity for the company and engage with the private investor community as there are numerous opportunities to do so. He could take a lead from Cathal Friel from Open Orphan who seems to speak frequently at online investor events where he presents and answers questions from new and existing shareholders
Agree that it is foolish to accept anything said on bulletin boards and that is why I would prefer to listen to the call myself. Even with the best intentions, people can wrongly report conversations or misinterpret information or read too much into what is said.
I don't understand why access to this call should not be opened up would as it would put everyone on a level playing field. Plus there are platforms that allow this https://www.investormeetcompany.com/
Even a simple audio call open to all with questions sent in in advance would be sufficient.
While it is great that Peter is have calls with a number of shareholders that leveraged the call by using the percentage of shareholdings on this board, it seem arbitrary to me at least who is allowed on that call.
Is it to do with your shareholding or who you know or can others join? Maybe I missed a message asking for those interested so apologies in advance if there was?
Note, I had previously asked the company to use the platform https://www.investormeetcompany.com/ to engage with Private shareholders as it would create a level playing field but did not get a positive enough response. To me, it is a no brainer for companies that care about their private shareholders.
BTW I do appreciate the feedback from the calls.
Still heavy underwater here - had virtually written it off a perennial disappointer but maybe there is hope.
Fincap also giving their view - there are a few tweets.
https://twitter.com/Savannah_Energy
Bet is in the royal free hospital as Cathal said it had been leaked in the press and I found any article it
mentione
in guardian or Telegragh.
Also has the required negative air pressure facility to stop cross contamination of air between patients as mentioned by Cathal at the analyst call yesterday
https://www.royalfree.nhs.uk/services/services-a-z/infectious-diseases/high-level-isolation-unit/
Anyway, bit that important in the scheme of things as we have an over 20p party
Adam Hargreaves
https://www.linkedin.com/in/adam-hargreaves-53372ab